LRP1 and Cognitive impairment: In conclusion, our study contributes the MDK‐LRP1 axis as a mechanistic bridge between renal injury, hippocampal neuroinflammation and cognitive decline after AKI, offering new therapeutic targets for post‐AKI cognitive impairment.